logo
Select company
Select metric
$ 0Net Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
43
Sector
75
Industry
55
History
95
$ 1.04Close
$ 0.72 - $ 1.6 52-Week Range
Ticker Information

Ticker

TXMD

Company Name

THERAPEUTICSMD INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

THERAPEUTICSMD INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TXMD - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 2M
6/30/2024$ 2M
3/31/2024$ 3.15M
12/31/2023$ 3.15M
9/30/2023$ 1.15M
6/30/2023$ 3.6M
3/31/2023$ 2.47M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • THERAPEUTICSMD INC's latest trailing twelve months (TTM) CF - Equity stands at $ 77.3M.
  • Over the past 5 years, THERAPEUTICSMD INC's average CF - Equity has been $ 48.29M.
  • The median CF - Equity for THERAPEUTICSMD INC during this period was $ 3.38M
  • THERAPEUTICSMD INC reached its highest CF - Equity over the past 5 years at $ 215.02M.
  • The lowest CF - Equity recorded by THERAPEUTICSMD INC in the same timeframe $ 0

THERAPEUTICSMD INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
LGVN : LONGEVERON INC $ 14MTRAW : TRAWS PHARMA INC $ 23.37MTNON : TENON MEDICAL INC $ 16.39MPRPH : PROPHASE LABS INC $ 6.53MCYCN : CYCLERION THERAPEUTICS INC $ 1.38MLUCY : INNOVATIVE EYEWEAR INC $ 11.07MINBS : INTELLIGENT BIO SOLUTIONS INC $ 4.6MSINT : SINTX TECHNOLOGIES INC $ 7.21MTLPH : TALPHERA INC $ -1.51MXBIO : XENETIC BIOSCIENCES INC $ 0

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

TXMD - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Dec 31, 2024

$ 215.02M

Maximum

Sep 30, 2021

$ 48.29M

Average

$ 3.38M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 98.02K with a standard deviation of $ 17.64M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 98.02K
median$ 0
std$ 17.64M